# Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System

> **NCT02798328** · — · COMPLETED · sponsor: **Haemonetics Corporation** · enrollment: 385 (actual)

## Conditions studied

- DOAC Eligible Subjects

## Interventions

- **DEVICE:** TEG6s DOAC Cartridge

## Key facts

- **NCT ID:** NCT02798328
- **Lead sponsor:** Haemonetics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2017-09
- **Final completion:** 2017-09
- **Target enrollment:** 385 (ACTUAL)
- **Last updated:** 2020-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02798328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02798328, "Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02798328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*